Drugs / Eptoposide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00836173 Background | Jul 2008 → May 2012 | diffuse large B-cell lymphoma | Loyola University | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Eptoposide | “Eptoposide by intravenous infusion over 2 hours on day 3-5” NCT00836173 ↗ |
| Route | Intravenous | “Eptoposide by intravenous infusion” NCT00836173 ↗ |